Solid Biosciences Inc. (SLDB)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Solid Biosciences Inc. (SLDB) is up 47.2% since the beginning of the year. At $8 per share, SLDB is trading 6.4% below its 52-week high of $9. Investors who bought $1,000 worth of SLDB shares 5 years ago would now be looking at an investment worth $142.

Solid Biosciences Inc. (SLDB) has returned 47.16% so far this year and 73.28% over the past 12 months.

Based on dividend-adjusted daily data since Jan 26, 2018, SLDB's average daily return is +0.08%, while the average monthly return is +1.44%. At this rate, an investment would double in approximately 4.0 years.

Historically, 45% of months were positive and 55% were negative. The best month was Dec 2020 with a return of +129.0%, while the worst month was Mar 2018 at -74.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, SLDB closed higher 45% of trading days. The best single day was Oct 1, 2020 with a return of +70.4%, while the worst single day was Nov 12, 2019 at -74.4%.

Solid Biosciences Inc. has an annualized alpha of 2.53%, beta of 1.23, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since January 26, 2018.

• This stock participated in 222.70% of S&P 500 Index downside but only 101.30% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SLDB ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Solid Biosciences Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Solid Biosciences Inc. was 99.76%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Solid Biosciences Inc. drawdown is 98.93%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Solid Biosciences Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Solid Biosciences Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.